Improving cancer care in a Kentucky managed care plan: A case study of cancer disease management

Disease Management

Volumn 6, Issue 1, 2003, Pages 9-20

  Costich, Timothy D ^a   Lee, Frederick C ^b  

^a CHA HMO Inc   (United States)

^b Quality Oncology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER; CANCER CENTER; CLINICAL PRACTICE; COOPERATION; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MANAGED CARE; MEDICAL RESEARCH; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT CARE; PATIENT SATISFACTION; PRACTICE GUIDELINE; RURAL AREA; UNITED STATES;

EID: 0037359442     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109350703321530837     Document Type: Article

References (30)

1. Desch CE, Hillner BE, Smith TJ. Economic considerations in the care of lung cancer patients. Curr Opin Oncol 1996;8:126-132.
2. SRI Consulting. C4: cancer opportunities in the new millennium. Menlo Park, CA: SRI Consulting, 2000.
3. Browman G, Brouwers M, DeVito C, Johnston M, Graham I. Participation patterns of oncologists in the development of clinical practice guidelines. Curr Oncol 2000;7(4):252-257.
4. Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995;13:502-512.
5. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs 2000;19(2):110-128.
6. Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 2000;356:1148-1152.
7. Sanoshy JK, West PA. The impact of clinical guidelines on oncology care. Oncol Issues 2002;July/August:20-25.
8. National Committee for Quality Assurance. Quality profiles. Washington, DC: National Committee for Quality Assurance, 1999:95-98.
9. Riley GF, Potosky AL, Lubitz JD, Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health 1994;84:1598-1604.
10. Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000;356:1326-1327.
11. Fallowfield L. Untreated depression in cancer patients. Br J Oncol 2001;242:1532-1537.
12. Rosenblatt L, Block SD. Depression, decision making and the cessation of life sustaining treatment. West J Med 2001;175:320-325.
13. Guadagnoli E, Weeks JC, Shapiro CL, Gurwitz CL, Borbas C, Soumerai SB. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 1998;16:101-106.
14. Middleton RG, Thompson IM, Austenfeld MS, et al. Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol 1995;154:2144-2148.
15. Specialists' biases influence what prostate cancer patients are told. Associated Press, June 27, 2000.
16. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer. JAMA 2000;283:354-360.
17. Wennberg JE, Cooper MM, eds. The Dartmouth atlas of health care 1998. Chicago: American Hospital Publishing, 1998.
18. Birkmeyer JD. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-1144.
19. Yao SL, Lu-Yao G. Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay. J Natl Cancer Inst 1999;91:1950-1956.
20. Begg CB, Cramer LD, Hoskins WJ, Brennan ME. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280:1747-1751.
21. Smith S. CDC targets crisis in hospital-stay infections. Boston Globe. March 27, 2002, D-1.
22. Sabin JE. Making insurance coverage for new technologies reasonable and accountable. JAMA 1998;279:703-704.
23. Rischer JB, Childress SB. Cancer pain management: pilot implementation of the AHCPR guideline in Utah. J Qual Improv 1996;22:683-700.
24. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-596.
25. Fortner BV. Management of breakthrough pain in cancer patients. J Pain 2002;3:38-44.
26. Drayer RA, Henderson J, Reidenberg M. Barriers to better pain control in hospitalized patients. J Pain Symptom Manage 1999;17:434-440.
27. Lundberg GD, Copeland H, Smith T. The best health care goes only so far. Newsweek. August 27, 2001:15.
28. Biermann C, Copeland H, Smith T. Satisfaction with care not related to quality of life for cancer patients. Reuters, October 24, 2000.
29. Lee F. Managing oncology care. Managing Employee Benefits 1997;5(2):75-81.
30. Healthcare Demand and Disease Management. Breast cancer disease management programs focus on prevention, treatment, patient empowerment. Atlanta: Healthcare Demand and Disease Management, 1997: 102-107.